Myxovirus Resistance Proteins
"Myxovirus Resistance Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Interferon-induced DYNAMIN-like GTP-binding proteins localized in the cytoplasm, nuclear pore complex and nucleus. They play a role in antiviral defense and immunity.
Descriptor ID |
D064547
|
MeSH Number(s) |
D08.811.277.040.330.300.550 D12.776.157.325.636
|
Concept/Terms |
Myxovirus Resistance Proteins- Myxovirus Resistance Proteins
- Proteins, Myxovirus Resistance
- Resistance Proteins, Myxovirus
- Protein Mx
- Mx, Protein
- Protein Mx, Interferon-Induced
- Interferon-Induced Protein Mx
- Mx, Interferon-Induced Protein
- Protein Mx, Interferon Induced
|
Below are MeSH descriptors whose meaning is more general than "Myxovirus Resistance Proteins".
Below are MeSH descriptors whose meaning is more specific than "Myxovirus Resistance Proteins".
This graph shows the total number of publications written about "Myxovirus Resistance Proteins" by people in this website by year, and whether "Myxovirus Resistance Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 | 2006 | 0 | 1 | 1 | 2011 | 0 | 1 | 1 | 2014 | 1 | 0 | 1 | 2016 | 0 | 1 | 1 | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Myxovirus Resistance Proteins" by people in Profiles.
-
Kane M, Rebensburg SV, Takata MA, Zang TM, Yamashita M, Kvaratskhelia M, Bieniasz PD. Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2. Elife. 2018 08 07; 7.
-
Lavender KJ, Gibbert K, Peterson KE, Van Dis E, Francois S, Woods T, Messer RJ, Gawanbacht A, M?ller JA, M?nch J, Phillips K, Race B, Harper MS, Guo K, Lee EJ, Trilling M, Hengel H, Piehler J, Verheyen J, Wilson CC, Santiago ML, Hasenkrug KJ, Dittmer U. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo. J Virol. 2016 07 01; 90(13):6001-6013.
-
Nagel MA, James SF, Traktinskiy I, Wyborny A, Choe A, Rempel A, Baird NL, Gilden D. Inhibition of phosphorylated-STAT1 nuclear translocation and antiviral protein expression in human brain vascular adventitial fibroblasts infected with varicella-zoster virus. J Virol. 2014 Oct; 88(19):11634-7.
-
Dionne KR, Galvin JM, Schittone SA, Clarke P, Tyler KL. Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection. J Neurovirol. 2011 Aug; 17(4):314-26.
-
Asokan R, Hua J, Young KA, Gould HJ, Hannan JP, Kraus DM, Szakonyi G, Grundy GJ, Chen XS, Crow MK, Holers VM. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. J Immunol. 2006 Jul 01; 177(1):383-94.
-
Malcolm KC, Worthen GS. Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem. 2003 May 02; 278(18):15693-701.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|